EUVIMEDEUVIMED entdecken
Crossref

Efficacy of sorafenib therapy in patients with advanced hepatocellular carcinoma in Indian population

Alit Abraham, Charumathi Purushothaman, Dhanya Damien, Jackson James, Prudence Attilade Rodrigues, Gursharan Singh

Hepatoma Research · 2016

DOI: 10.20517/2394-5079.2016.03 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatoma Research, 2016. Verfasst von Alit Abraham und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatoma Research is an open access journal and focuses on all topics related to hepatoma. The following articles are especially welcome: pathogenesis, clinical examination and early diagnosis of hepatoma, complications of hepatoma, and their preventions and treatments, etc.

Zitieren

APA

Abraham, A., Purushothaman, C., Damien, D., James, J., Rodrigues, P. A., & Singh, G. (2016). Efficacy of sorafenib therapy in patients with advanced hepatocellular carcinoma in Indian population. Hepatoma Research. https://doi.org/10.20517/2394-5079.2016.03

Vancouver

Abraham A, Purushothaman C, Damien D, James J, Rodrigues PA, Singh G. Efficacy of sorafenib therapy in patients with advanced hepatocellular carcinoma in Indian population. Hepatoma Research. 2016. doi:10.20517/2394-5079.2016.03

BibTeX
@article{Abraham2016,
  author = {Abraham, Alit and Purushothaman, Charumathi and Damien, Dhanya and James, Jackson and Rodrigues, Prudence Attilade and Singh, Gursharan},
  title = {Efficacy of sorafenib therapy in patients with advanced hepatocellular carcinoma in Indian population},
  journal = {Hepatoma Research},
  year = {2016},
  doi = {10.20517/2394-5079.2016.03}
}
Kostenlos starten →